New York, NY -- (SBWIRE) -- 11/08/2012 -- Amarantus BioSciences Inc. (OTC:AMBS) traded in the range of $0.05 and $0.07 during its latest trading session. The stock recorded the volume of 45.954 million shares, significantly higher than its average daily trading volume of 699k shares. Its down movement accompanied by high volume betrays bearish trend. However, its MACD and EMA charts shows neutral trend. The stock had opened at $0.07 and closed at $0.05, down 28.43 percent from its previous close of $0.07. It is currently trading above its 10 days EMA of $0.03 and has its first support level at $0.01. In the intermediate time period, the stock is likely to remain neutral mode.
Find out where AMBS will be heading by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=AMBS
A123 Systems (OTCQB: AONEQ) stock closed its latest trading session at $0.10, down 21.54 percent from its previous close of $0.12. The stock opened the session at $0.11 and touched its lowest price point at $0.09. A123 Systems stock’s highest price point for the session stood at $0.11. The stock is currently below its 6-days EMA of $0.13 and its 20 days EMA of $0.16, thus showing mildly bearish trend. However, its MACD chart also shows bearish trend and the stock is likely to make mild downward movement in coming trading sessions.
Find out if AONEQ will bounce back in the very short term by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=AOENQ
Federal National Mortgage Association (OTCQB: FNMA) traded in the range of $0.28 and $0.30 during its latest trading session. The stock had opened at $0.28 and closed at $0.30, up 8.07 percent from its previous close of $0.27. Federal National Mortgage recorded the volume of 17.270 million shares, significantly higher than its average daily trading volume of 3.513 million shares, thus showing bullish trend. The stock has overall neutral trend as per its MACD chart. Federal National Mortgage has its first resistance level at $0.31. Its first support level stands at $0.29 and its second level support is at $0.28.
Find out if FNMA will maintain its momentum by getting the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=FNMA
Nestle (PINKSHEETS: NSRGY) stock closed its latest trading session at $63.02, down 0.63 percent from its previous close of $63.42. The stock shows mild bearish trend as it made the down move with trading volume of 438k shares, in contrast to the average daily trading volume of 439k shares. Its bearish trend is further confirmed by its MACD chart and the stock is also trading lower than its 6 days EMA of $63.32. The stock may go as low as $68.52 in its coming trading sessions. Upon breaching this level, the stock may go down to the level of $67.39.
Find out more about NSRGY by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=NSRGY
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
Alexander K. Neumann
WALL STREET REPORT